Rezultati pretraživanja
  1. 23. sij

    "Labs in China/Thailand have sequenced genomes of 19 strains... 'That’s pretty remarkable, given that we’re 2 weeks in,' says at . 'People are extremely fast/excellent w/ data sharing'"

    1 reply 2 proslijeđena tweeta 8 korisnika označava da im se sviđa
  2. 3. sij

    Pharmalot.. Pharmalittle.. Good Morning.. FDA urged to recall all forms of , end-of-year drug approvals have unintended consequences & more interesting news..

    2 proslijeđena tweeta 2 korisnika označavaju da im se sviđa
  3. 18. pro 2019.

    We are short - we see odds heavily stacked against Twist in upcoming early 2020 trial w/ Agilent; cash burn is out of control esp. w/ high 2020 litigation expense; and FTC suit should take deflate M&A hope

    6 proslijeđenih tweetova 15 korisnika označava da im se sviđa
  4. 17. pro 2019.

    The FTC blocks 's deal, calling DNA sequencing giant "a monopolist."

    19 proslijeđenih tweetova 26 korisnika označava da im se sviđa
  5. 13. pro 2019.

    *Current* "Genetic testing is an inexact science with real consequences". Using proper de novo sequencing of your whole genome (thank you ) instead of shotgunning for tiny matches to a reference genome will improve things.

    2 proslijeđena tweeta 2 korisnika označavaju da im se sviđa
  6. 18. lip 2019.

    Genomic testing stocks in play: and Invitae (I own the latter two)

    5 proslijeđenih tweetova 1 korisnik označava da mu se sviđa
  7. 7. svi 2019.

    Can Be Good for Your

    13 korisnika označava da im se sviđa
  8. 2. stu 2018.

    LIVE: and shares have both dropped, is up over 67%, and is down almost 2%.

    3 korisnika označavaju da im se sviđa
  9. 2. stu 2018.

    Illumina +5%. Cowen w/buy and $400 tgt.

    1 reply 1 proslijeđeni tweet 7 korisnika označava da im se sviđa
  10. 2. stu 2018.

    (+67.0% pre) Gene sequencing company Illumina to buy Pacific Biosciences in $1.2 billion deal - Reuters

    3 proslijeđena tweeta 2 korisnika označavaju da im se sviđa
  11. 2. stu 2018.

    company to buy smaller rival in an all-cash deal valued at $1.2 billion

    1 reply 7 proslijeđenih tweetova 8 korisnika označava da im se sviđa
  12. 1. stu 2018.

    just wow!! Illumina to acquire Pacific Biosciences at near-100% premium

    4 proslijeđena tweeta 10 korisnika označava da im se sviđa
  13. 1. stu 2018.

    Suprise, genomics folks! is buying for $1.2 billion. I spoke to CEO Francis deSouza about why.

    20 replies 441 proslijeđeni tweet 398 korisnika označava da im se sviđa
  14. 2. kol 2018.

    Sequel installbase grows from 250 to 275 in Q2 2018:

    1 proslijeđeni tweet 4 korisnika označavaju da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
  15. 2. svi 2018.

    earnings call transcript for Q1 2008 by Mike Hunkapiller

    6 proslijeđenih tweetova 6 korisnika označava da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
  16. 25. sij 2018.

    "the [genome is 10x] the size of our own... 32 billion DNA bases... Unfortunately, the [newly sequenced genome] don't shed much light on regeneration abilities... extra DNA carried by the axolotl doesn't SEEM to be doing anything useful."

    1 reply 2 proslijeđena tweeta 3 korisnika označavaju da im se sviđa
  17. 21. lis 2017.

    : GlaxoSmithKline adult shingles vaccine wins U.S. approval via @

    1 reply 4 proslijeđena tweeta 5 korisnika označava da im se sviđa
  18. 15. pro 2016.

    Today’s Losers: , ,

    1 reply 2 proslijeđena tweeta 3 korisnika označavaju da im se sviđa
  19. 3. velj 2016.

    (+0.0% pre) Roche eyes acquisition of Pacific Biosciences

    1 proslijeđeni tweet 5 korisnika označava da im se sviđa
  20. 2. velj 2016.

    sniffing out more bolt-on acquisitions, eying acquisition of Biosciences: sources

    1 proslijeđeni tweet 4 korisnika označavaju da im se sviđa

Nema rezultata.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.